These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 9516836

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma.
    Van Roy N, Cheng NC, Laureys G, Opdenakker G, Versteeg R, Speleman F.
    Eur J Cancer; 1995; 31A(4):530-5. PubMed ID: 7576960
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.
    Lastowska M, Van Roy N, Bown N, Speleman F, Roberts P, Lunec J, Strachan T, Pearson AD, Jackson MS.
    Med Pediatr Oncol; 2001 Jan; 36(1):20-3. PubMed ID: 11464884
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Promiscuous translocations of chromosome arm 17q in human neuroblastomas.
    Lastowska M, Roberts P, Pearson AD, Lewis I, Wolstenholme J, Bown N.
    Genes Chromosomes Cancer; 1997 Jul; 19(3):143-9. PubMed ID: 9218994
    [Abstract] [Full Text] [Related]

  • 10. Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells.
    Savelyeva L, Corvi R, Schwab M.
    Am J Hum Genet; 1994 Aug; 55(2):334-40. PubMed ID: 8037210
    [Abstract] [Full Text] [Related]

  • 11. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG.
    Verh K Acad Geneeskd Belg; 1995 Aug; 57(5):389-422. PubMed ID: 8571670
    [Abstract] [Full Text] [Related]

  • 12. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors.
    Łastowska M, Cotterill S, Bown N, Cullinane C, Variend S, Lunec J, Strachan T, Pearson AD, Jackson MS.
    Genes Chromosomes Cancer; 2002 Aug; 34(4):428-36. PubMed ID: 12112532
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD, U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
    [Abstract] [Full Text] [Related]

  • 19. Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics.
    Vandesompele J, Michels E, De Preter K, Menten B, Schramm A, Eggert A, Ambros PF, Combaret V, Francotte N, Antonacci F, De Paepe A, Laureys G, Speleman F, Van Roy N.
    Int J Cancer; 2008 Mar 01; 122(5):1177-82. PubMed ID: 17973261
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.